Prostaglandins in the management of cardiac and skeletal muscle ischemia.
Belkin
M
M
Department of Surgery, Tufts School of Medicine, New England.
Blebea
J
J
Wright
J G
JG
Hobson
R W
RW
D000818:Animals; D002415:Cats; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D011464:Epoprostenol / Q000494:pharmacology / Q000627:therapeutic use*; D016285:Iloprost; D007511:Ischemia / Q000188:drug therapy* / Q000503:physiopathology; D009132:Muscles / Q000098:blood supply*; D009504:Neutrophils / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011817:Rabbits; D014665:Vasodilator Agents / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents; D011464:Epoprostenol; D016285:Iloprost